The global nutragenomics market size is expected to reach US$ 2.11 Billion in 2032. The nutragenomics market is growing rapidly.
As per FMI Analysts, the global Nutragenomics market is estimated to be valued at US$ 538.90 Million in 2022 and is projected to increase at a CAGR of 16.48% in the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Nutragenomics Market Estimated Base Year Value (2021) | US$ 462.97 Million |
| Nutragenomics Market Expected Market Value (2022) | US$ 538.90 Million |
| Nutragenomics Market Anticipated Forecast Value (2032) | US$ 2.11 Billion |
| Nutragenomics Market Projected Growth Rate (2022 to 2032) | 16.48% CAGR |
The prevalence of genetic and chronic diseases has significantly increased so consumers are now being asked to take a nutragenomics test to find out if they have a preexisting or upcoming health issue due to eating a particular food product, driving growth in the nutragenomics market. Manufacturers are also attempting to use this process in order to understand a product's effect on its intended consumer before releasing it on the market.
The consumption of diets containing phenylalanine may interfere with the synthesis of proteins and enzymes. Kits of nutragenomics are also helpful in tracking nutritional consumption in a particular area or country. Nutragenomics manufacturers may be able to provide these tests at affordable prices. They may also try using other techniques for nutragenomics analysis; they may also consider the time duration of the analysis.
Nutragenomics manufacturers will be able to develop a rapid interaction detection technique between food and genes, as well as the interaction of nutrients with health and disease if manufacturers concentrate on regions involving Europe, Japan, and the USA for the maximum purchase of such products.
In addition, nutragenomics manufacturers can devise such kits and reagents that are easy for users to use, and results may be obtained in less time than other techniques. Nutragenomics may also be used to determine the amount of nutrient consumption in a particular area, as well as determine the toxicity of any products that may be used in the manufacture of foods that could be harmful to human health, registering high growth rates in the global nutrigenomics market.
Over the forecast period, North America is expected to lead the global nutrition genomics market, driven by the rapid adoption of personal genomics, the rising number of service providers, and the increasing prevalence of lifestyle-related diseases.
Companies like this are focusing on merging and collaborating with research facilities to develop ideal genetic tests. The main hurdle for manufacturers is developing better testing kits and having them approved by regulatory agencies. This is a change that will help fuel the nutragenomics market in the future.
Earlier this year, 23&Me teamed up with GlaxoSmithKline to research and developed innovative medicine, using genetics as the foundation to develop possible cures. To advance the understanding of human genetic diversity and to improve health outcomes for underrepresented populations in genetic research, 23&Me launched The Global Genetic Project in February 2018.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The nutragenomics market has received a lot of traction in the industry.
Gene-related and chronic diseases are becoming more common, which is why some consumers are undergoing nutragenomics tests to understand their preexisting health conditions and any potential health issues that may occur if they consume a particular food product. Manufacturers are attempting to use nutragenomics to determine whether a product will have an adverse effect on the consumer before releasing it, creating demand for nutrigenomics.
Nutragenomics kits are useful for tracking nutrient intake amongst consumers in a particular area or country. Consumers should avoid consuming phenylalanine-containing foods since they could interfere with protein synthesis and enzyme synthesis.
Companies that specialize in these fields might be able to create tests at an affordable price, or they might be able to use other techniques rather than blood and saliva for nutragenomics analysis, or they might be able to reduce the time needed for the analysis.
The manufacturers of nutragenomics kits should consider targeting regions like Europe, Japan, and the USA so that their products can be sold in greater numbers, such as kits used for their stringent and precise regulation of any food material. Integrating biological data sets along with nutragenomics approaches could lead to the development of a rapid interaction detection technique between food and genes as well as the relationship between nutrients and health, resulting in an increase in sales of nutrigenomics.
The North American nutrigenomics market is expected to outpace its global counterpart over the forecast period owing to the rapid adoption of personal genomics, the increase in the number of service providers, and the rising prevalence of lifestyle-related diseases.
It is predicted that the nutrigenomics market in Europe will expand during the forecast period as a result of increased research, strategic collaborations, and active government support.
The Asia Pacific is expected to drive notable growth in the nutragenomics market due to the large number of patients suffering from lifestyle diseases, in addition to lucrative pricing strategies being applied by various start-up companies in these regions.
According to a survey by a research institution in nine countries with 9000 participants, nutrigenomics has been widely accepted, and people are ready to adopt it if offered a legal guarantee that genetic data will not be misused. The Asia Pacific region is also expected to experience strong growth in the nutragenomics market due to the growing demand for functional foods and beverages that have elevated the adoption of nutrigenomic techniques.
Principal Consultant
Some of the leading companies operating in the global nutragenomics market include Koninklijke DSM N.V., BASF SE, Danone SA, Genova Diagnostics, Inc., Nutrigenomix Inc., The Unilever Group, XCode Life Sciences Private Limited, WellGen, Inc., Integrative Medicine Communications. Inc., and Receptor Logic, Inc.
There are many companies that are focusing on acquiring and collaborating with various facilities for the development of ideal genetic tests. The development of better testing kits and their approval by regulatory bodies is the main hurdle facing all of these companies, and these changes will help propel the nutragenomics market growth in the future.
A collaboration between 23&Me and GlaxoSmithKline took place in June 2018. This collaboration will focus on investigating and developing innovative medicines and potential cures using human genetics as a starting point.
With the launch of The Global Genetic Project in February 2018, 23&Me seeks to improve its understanding of human genetic diversity and provide insights into health conditions that may affect populations underrepresented in genetic research, thereby affecting the growth rate in the global nutragenomics market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 16.48% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global nutrigenomics market is set to exceed US$ 2.11 Billion by 2032.
The USA is projected to lead the nutrigenomics market in the forecast period.
Koninklijke DSM N.V., BASF SE, Danone SA, and Genova Diagnostics, Inc. are some of the renowned companies in the nutrigenomics market.
1. Global Market Executive Summary | Nutragenomics Market 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Nutragenomics 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis - 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Million) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long-Term Forecast 3.1.4.3. Quarter-by-Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Nutragenomics 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032 5.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021 5.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Million) Analysis By Product, 2017 to 2021 6.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Product, 2022 to 2032 6.3.1. Services 6.3.2. Reagents & Kits 6.4. Market Attractiveness Analysis By Product 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Technique 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Million) Analysis By Technique, 2017 to 2021 7.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Technique, 2022 to 2032 7.3.1. Blood 7.3.2. Saliva 7.3.3. Buccal Swab 7.3.4. Others 7.4. Market Attractiveness Analysis By Technique 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Million) Analysis By Application, 2017 to 2021 8.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032 8.3.1. Diabetics Pharmaceuticals 8.3.2. Cardiovascular 8.3.3. Anti-aging 8.3.4. Chronic Diseases 8.3.5. Others 8.4. Market Attractiveness Analysis By Application 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Million) Analysis By Region, 2017 to 2021 9.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.3. Market Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.3.1. By Country 10.3.1.1. USA 10.3.1.2. Canada 10.3.2. By Product 10.3.3. By Technique 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Product 10.4.3. By Technique 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Product 11.3.3. By Technique 11.3.4. By Application 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product 11.4.3. By Technique 11.4.4. By Application 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Product 12.3.3. By Technique 12.3.4. By Application 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By Technique 12.4.4. By Application 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Product 13.3.3. By Technique 13.3.4. By Application 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Technique 13.4.4. By Application 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. Australia and New Zealand 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Product 14.3.3. By Technique 14.3.4. By Application 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Technique 14.4.4. By Application 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.3. Current and Future Market Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Product 15.3.3. By Technique 15.3.4. By Application 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Technique 15.4.4. By Application 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.4. Koninklijke DSM N.V. 17.4.1. Company Overview 17.4.2. Product Overview 17.4.3. SWOT Analysis 17.4.4. Key Developments 17.5. BASF SE 17.5.1. Company Overview 17.5.2. Product Overview 17.5.3. SWOT Analysis 17.5.4. Key Developments 17.6. Danone SA 17.6.1. Company Overview 17.6.2. Product Overview 17.6.3. SWOT Analysis 17.6.4. Key Developments 17.7. Genova Diagnostics, Inc. 17.7.1. Company Overview 17.7.2. Product Overview 17.7.3. SWOT Analysis 17.7.4. Key Developments 17.8. Nutrigenomix Inc. 17.8.1. Company Overview 17.8.2. Product Overview 17.8.3. SWOT Analysis 17.8.4. Key Developments 17.9. The Unilever Group 17.9.1. Company Overview 17.9.2. Product Overview 17.9.3. SWOT Analysis 17.9.4. Key Developments 17.10. XCode Life Sciences Private Limited 17.10.1. Company Overview 17.10.2. Product Overview 17.10.3. SWOT Analysis 17.10.4. Key Developments 17.11. WellGen, Inc. 17.11.1. Company Overview 17.11.2. Product Overview 17.11.3. SWOT Analysis 17.11.4. Key Developments 17.12. Integrative Medicine Communications. Inc. 17.12.1. Company Overview 17.12.2. Product Overview 17.12.3. SWOT Analysis 17.12.4. Key Developments 17.13. Receptor Logic, Inc. 17.13.1. Company Overview 17.13.2. Product Overview 17.13.3. SWOT Analysis 17.13.4. Key Developments 17.14. Vizag Chemical International 17.14.1. Company Overview 17.14.2. Product Overview 17.14.3. SWOT Analysis 17.14.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Explore Food and Beverage Insights
View Reports
Nutragenomics Market
